Chemical and Pharmaceutical Bulletin p. 1130 - 1134 (1998)
Update date:2022-08-03
Topics:
Baba, Atsuo
Makino, Haruhiko
Ohta, Yoshikazu
Sohda, Takashi
The metabolites of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2- (1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (1, TAK-603), which is under clinical evaluation as a new type of disease-modifying antirheumatic drug (DMARD), were prepared to confirm th
View MoreContact:+86-913-2223392
Address:No. 32, Xinanjing Road, Weinan City, Shaanxi Province, 714000, China
Suzhou Sibian Chemical Technology Co., Ltd
website:http://www.sibianpharm.com
Contact:+8618169181984,+8618013186906
Address:Room1404,BuildingA,Jiabao Square No.323 Baodai East Road,Wuzhong District,Suzhou Jiangsu China (215128)
Shanghai Goyic Pharmaceutical&Chemical Co,. Ltd
Contact:+86-021-60275964
Address:No. 528 ruiqing road
Contact:13813902930 025-52714267
Address:20 Fengji Road, Yuhua Economic Development Zone, Nanjing, Jiangsu, P. R. China
Wuxi Morality Chemical Co., Ltd
Contact:
Address:B/7F, 321th WuYun Rd, Wanda Plaza, Wuxi City, 214174, China
Doi:10.1039/c6cc05707a
(2016)Doi:10.1039/a802797h
(1998)Doi:10.1039/a801922c
(1998)Doi:10.1021/jo01046a525
(1963)Doi:10.1016/j.jfluchem.2005.03.020
(2005)Doi:10.1055/s-2006-950244
(2006)